Bibliography
- Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29
- Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008;9:9-14
- Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-11
- Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(Suppl 1):i16-35
- Colombel JF, Rutgeerts P, Reinisch W, et al. SONIC: A randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. Gut 2008;57(Suppl II):OP001
- Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 Crohn's disease patients: results from a single centre cohort. Gut 2008, PMID:18832524
- The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78
- Brinar M, de Hertogh G, Karmiris K, et al. Allelic variations of autophagy-related 16-like 1 gene and immunity related guanosine phosphatase gene and granuloma formation in patients with Crohn's disease. Gut 2008;57(Suppl II):OP423
- Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008;456;259-63
- Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008;456:264-8
- Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008;134:743-56
- Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-29
- Urano F, Wang X, Bertolotti A, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000;287:664-6
- Zaph C, Troy AE, Taylor BC, et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007;446:552-6
- Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007;446:557-61
- Scaldaferri F, Phillips M, Rhee M, et al. Mucosal nonimmune cells produce pro-inflammatory mediators in response to Toll-like (TLRs) and NOD-like receptors (NLRs) ligands: Mesenchymal and endothelial cells as novel players of intestinal innate immunity. Gut 2008b;57(Suppl II):OP044
- Scaldaferri A, Rieder F, West G, et al. Intestinal fibroblasts generate FoxP3+ regulatory T cells (Tregs) through the PDL-1/PD-1 pathway: A novel regulatory mechanism of intestinal immunity. Gut 2008a;57(Suppl II):OP 046
- Vetrano S, Borroni EM, Savino B, et al. The chemokine decoy receptor D6 controls intestinal inflammation and inflammation-associated colon cancer. Gut 2008;57(Suppl II):OP036
- Walters MJ, Berahovich R, Wang Y, et al. Presence of CCR9 and its ligand CCL25/TECK in the colon: Scientific rationale for the use of CCR9 small molecule antagonist CCX282-B in colonic disorders. Gut 2008;57(Suppl II):OP184
- Alex P, Gonzales L, Zachos N, et al. Unraveling the long-standing mystery of smoking in IBD: NACHRA7, a novel master regulator and an effective therapeutic target in IBD. Gut 2008;57(Suppl II):OP180